RU2010149861A - Имплантаты назолакримальной дренажной системы для медикаментозной терапии - Google Patents
Имплантаты назолакримальной дренажной системы для медикаментозной терапии Download PDFInfo
- Publication number
- RU2010149861A RU2010149861A RU2010149861/14A RU2010149861A RU2010149861A RU 2010149861 A RU2010149861 A RU 2010149861A RU 2010149861/14 A RU2010149861/14 A RU 2010149861/14A RU 2010149861 A RU2010149861 A RU 2010149861A RU 2010149861 A RU2010149861 A RU 2010149861A
- Authority
- RU
- Russia
- Prior art keywords
- opening
- drug core
- implant
- lacrimal
- eye
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
- A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
- A61F9/0026—Ophthalmic product dispenser attachments to facilitate positioning near the eye
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/00772—Apparatus for restoration of tear ducts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/00781—Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0008—Fixation appliances for connecting prostheses to the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0085—Identification means; Administration of patients
- A61F2250/0087—Identification means; Administration of patients colour-coded
Abstract
1. Имплантат для вставления в отверстие слезного канала пациента, включающий: ! лекарственную сердцевину, имеющую дистальный конец и проксимальный конец, причем дистальный конец лекарственной сердцевины имеет перечное сечение, пригодное для вставления в отверстие слезного канала, причем лекарственная сердцевина включает лечебный агент, доставляемый в глаз; и ! оболочку, расположенную поверх части лекарственной сердцевины для задания, по крайней мере, одной экспонированной поверхности лекарственной сердцевины, где, по крайней мере, одна экспонированная поверхность лекарственной сердцевины расположена рядом с проксимальным концом для контакта со слезой или жидкостью слезной пленки и высвобождения лечебного агента на лечебных уровнях на протяжении пролонгированного периода, когда имплантат вставлен для использования. ! 2. Имплантат по п.1, дополнительно включающий удерживающую структуру, присоединенную к лекарственной сердцевине для удержания лекарственной сердцевины рядом с отверстием слезного канала и/или в нем. ! 3. Имплантат по п.2. где удерживающая структура включает гидрогель, приспособленный для расширения, когда удерживающая структура помещена в отверстие слезного канала. ! 4. Имплантат по п.3, где удерживающая структура включает прикрепляющий элемент, имеющий аксиально ориентированную поверхность, а гидрогель способен расширяться, побуждая аксиально ориентированную поверхность удерживать гидрогель, когда гидрогель гидратирован. ! 5. Имплантат по п.4, где прикрепляющий элемент включает, по крайней мере, одно из: выступа, кромки, ободка, или отверстия сквозь часть удерживающей структуры. ! 6. Имп�
Claims (23)
1. Имплантат для вставления в отверстие слезного канала пациента, включающий:
лекарственную сердцевину, имеющую дистальный конец и проксимальный конец, причем дистальный конец лекарственной сердцевины имеет перечное сечение, пригодное для вставления в отверстие слезного канала, причем лекарственная сердцевина включает лечебный агент, доставляемый в глаз; и
оболочку, расположенную поверх части лекарственной сердцевины для задания, по крайней мере, одной экспонированной поверхности лекарственной сердцевины, где, по крайней мере, одна экспонированная поверхность лекарственной сердцевины расположена рядом с проксимальным концом для контакта со слезой или жидкостью слезной пленки и высвобождения лечебного агента на лечебных уровнях на протяжении пролонгированного периода, когда имплантат вставлен для использования.
2. Имплантат по п.1, дополнительно включающий удерживающую структуру, присоединенную к лекарственной сердцевине для удержания лекарственной сердцевины рядом с отверстием слезного канала и/или в нем.
3. Имплантат по п.2. где удерживающая структура включает гидрогель, приспособленный для расширения, когда удерживающая структура помещена в отверстие слезного канала.
4. Имплантат по п.3, где удерживающая структура включает прикрепляющий элемент, имеющий аксиально ориентированную поверхность, а гидрогель способен расширяться, побуждая аксиально ориентированную поверхность удерживать гидрогель, когда гидрогель гидратирован.
5. Имплантат по п.4, где прикрепляющий элемент включает, по крайней мере, одно из: выступа, кромки, ободка, или отверстия сквозь часть удерживающей структуры.
6. Имплантат по п.2, где удерживающая структура способна к расширению между конфигурацией с малым сечением, пригодной для вставления, и конфигурацией с большим сечением для закрепления удерживающей структуры в просвете канальца.
7. Имплантат по п.2, где удерживающая структура расположена, по крайней мере, частично поверх лекарственной сердцевины.
8. Имплантат по п.1, где оболочка включает слой, расположенный поверх лекарственной сердцевины, для ингибирования высвобождения лечебного агента через слой.
9. Имплантат по п.8, где лекарственная сердцевина высвобождает лечебный агент через экспонированную поверхность.
10. Имплантат по п.1, где лекарственная сердцевина высвобождает лечебный агент на лечебных уровнях на протяжении периода времени, по крайней мере, одной недели, когда имплантат вставлен с поверхностью, экспонированной в слезу или жидкость слезной пленки.
11. Имплантат по п.1, где лекарственная сердцевина включает включения агента, и агент растворим в лекарственной сердцевине для обеспечения по существу однородной скорости высвобождения, когда лекарственная сердцевина имплантирована.
12. Имплантат по п.1, дополнительно включающий окклюзионный элемент для ингибирования тока слезной жидкости через просвет канальца.
13. Способ лечения глаза лечебным агентом, включающий;
вставление удерживающей структуры и дистального конца лекарственной сердцевины имплантата в отверстие слезного канала;
доставку лечебного агента из лекарственной сердцевины к глазу;
ограничение экспонированной поверхности лекарственной сердцевины рядом с проксимальным концом лекарственной сердцевины при помощи оболочки, где экспонированная поверхность контактирует со слезой или жидкостью слезной пленки, а лечебный агент мигрирует из экспонированной поверхности к глазу на протяжении пролонгированного периода, в то время как лекарственная сердцевина удерживается рядом с отверстием слезного канала посредством удерживающей структуры.
14. Способ лечения глаза, включающий:
вставление дистального конца имплантата в отверстие слезного канала;
расширение удерживающей структуры имплантата так, чтобы ингибировать выталкивание имплантата, причем расширение имплантата помогает закрыть поток слезной жидкости через отверстие слезного канала;
доставку лечебного агента от проксимального конца имплантата к слезной жидкости, касающейся глаза; и
ингибирование доставки лечебного агента дистально от проксимального конца.
15. Способ по п.14, где доставку лечебного агента к слезе ингибируют при помощи оболочки, имеющей часть, экспонированную в слезную жидкость.
16. Способ по п.14, где удерживающая структура включает гидрогель и распространяется дистально от лекарственной сердцевины.
17. Имплантат для лечения глаза, где глаз имеет слезную жидкость и отверстие слезного канала, включающий:
лекарственную сердцевину, имеющую проксимальный конец, дистальный конец и поперечное сечение, пригодное для вставления в отверстие слезного канала;
манжету, расположенную поверх лекарственной сердцевины, по крайней мере, дистально от проксимального конца; и
способный к набуханию материал, расположенный дистально от проксимального конца и, по крайней мере, частично покрытый манжетой, где способный к набуханию материал приспособлен набухать после вставления в отверстие слезного канала для удержания лекарственной сердцевины и препятствия слезе, находящейся в жидкостном контакте с лекарственной сердцевиной.
18. Имплантат по п.17, где манжета включает лепестки для удержания пробки для отверстия слезного канала при расширении способного к набуханию материала.
19. Пробка для отверстия слезного канала для лечения глаза, где глаз имеет слезную жидкость и отверстие слезного канала, включающая:
корпус пробки; и
лекарственную сердцевину внутри корпуса пробки, где лекарственная сердцевина включает смесь лечебного агента и матрикса, где поверхность сердцевины экспонирована в слезную жидкость для лечения глаза.
20. Пробка для отверстия слезного канала по п.19, где лекарственная сердцевина способна к эластичному расширению для того, чтобы вмещать иглу, вставляемую в нее, когда пробка вставлена в отверстие слезного канала газа.
21. Пробка для отверстия слезного канала для лечения глаза, где глаз имеет слезную жидкость и отверстие слезного канала, включающая:
способный к расширению удерживающий элемент для расширения и вхождения в зацепление с отверстием слезного канала при размещении в отверстии слезного канала; и
корпус, соединенный со способным к расширению удерживающим элементом, где корпус включает выступ для удаления удерживающего элемента из отверстия слезного канала.
22. Пробка для отверстия слезного канала по п.21, где способный к расширению удерживающий элемент включает способный к набуханию материал, а корпус приспособлен для удерживания способного к набуханию материала при удалении корпуса.
23. Пробка для отверстия слезного канала по п.22, где способный к набуханию материал включает гидрогель.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78777506P | 2006-03-31 | 2006-03-31 | |
US60/787,775 | 2006-03-31 | ||
US87186406P | 2006-12-26 | 2006-12-26 | |
US60/871,864 | 2006-12-26 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2008143224/14A Division RU2414199C2 (ru) | 2006-03-31 | 2007-04-02 | Имплантаты назолакримальной дренажной системы для медикаментозной терапии |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2010149861A true RU2010149861A (ru) | 2012-06-10 |
Family
ID=38564290
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2008143224/14A RU2414199C2 (ru) | 2006-03-31 | 2007-04-02 | Имплантаты назолакримальной дренажной системы для медикаментозной терапии |
RU2008143223/14A RU2413480C2 (ru) | 2006-03-31 | 2007-04-02 | Способы доставки лекарственных средств, структуры и композиции для носослезной системы |
RU2010149066/14A RU2010149066A (ru) | 2006-03-31 | 2010-11-30 | Способы доставки лекарственных средств, структуры и композиции для носослезной системы |
RU2010149861/14A RU2010149861A (ru) | 2006-03-31 | 2010-12-03 | Имплантаты назолакримальной дренажной системы для медикаментозной терапии |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2008143224/14A RU2414199C2 (ru) | 2006-03-31 | 2007-04-02 | Имплантаты назолакримальной дренажной системы для медикаментозной терапии |
RU2008143223/14A RU2413480C2 (ru) | 2006-03-31 | 2007-04-02 | Способы доставки лекарственных средств, структуры и композиции для носослезной системы |
RU2010149066/14A RU2010149066A (ru) | 2006-03-31 | 2010-11-30 | Способы доставки лекарственных средств, структуры и композиции для носослезной системы |
Country Status (19)
Country | Link |
---|---|
US (17) | US7998497B2 (ru) |
EP (3) | EP3449873A1 (ru) |
JP (10) | JP2009532132A (ru) |
KR (4) | KR20110038144A (ru) |
CN (2) | CN103393496B (ru) |
AU (2) | AU2007234447B2 (ru) |
BR (2) | BRPI0709663A2 (ru) |
CA (2) | CA2648421C (ru) |
DK (2) | DK2010096T3 (ru) |
ES (2) | ES2717607T3 (ru) |
HK (2) | HK1190908A1 (ru) |
IL (5) | IL194514A0 (ru) |
MX (2) | MX2008012601A (ru) |
NO (2) | NO20084275L (ru) |
NZ (4) | NZ595349A (ru) |
RU (4) | RU2414199C2 (ru) |
SG (2) | SG170816A1 (ru) |
WO (2) | WO2007115259A2 (ru) |
ZA (2) | ZA200808401B (ru) |
Families Citing this family (167)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9808052D0 (en) | 1998-04-17 | 1998-06-17 | Secr Defence | Implants for administering substances and methods of producing implants |
US7431710B2 (en) | 2002-04-08 | 2008-10-07 | Glaukos Corporation | Ocular implants with anchors and methods thereof |
US20040225250A1 (en) | 2003-05-05 | 2004-11-11 | Michael Yablonski | Internal shunt and method for treating glaucoma |
US7291125B2 (en) | 2003-11-14 | 2007-11-06 | Transcend Medical, Inc. | Ocular pressure regulation |
US20050232972A1 (en) * | 2004-04-15 | 2005-10-20 | Steven Odrich | Drug delivery via punctal plug |
CA2572592C (en) | 2004-07-02 | 2015-09-08 | Eliot Lazar | Treatment medium delivery device and methods for delivery of such treatment mediums to the eye using such a delivery device |
ES2432556T3 (es) | 2004-08-04 | 2013-12-04 | Evonik Corporation | Métodos para fabricar dispositivos de suministro y sus dispositivos |
DK1933810T3 (da) | 2005-08-11 | 2013-01-28 | Childrens Medical Center | Intravesikal lægemiddelafgivelsesindretning og fremgangsmåde |
ES2380651T3 (es) * | 2005-09-01 | 2012-05-17 | Bristol-Myers Squibb Company | Biomarcadores y procedimientos para determinar la sensibilidad a moduladores de recpetor 2 del factor de crecimiento endotelial vascular |
US20070212397A1 (en) * | 2005-09-15 | 2007-09-13 | Roth Daniel B | Pharmaceutical delivery device and method for providing ocular treatment |
CA2625264C (en) | 2005-10-13 | 2015-12-15 | Synthes (U.S.A.) | Drug-impregnated sleeve for a medical implant |
CA2637602C (en) | 2006-01-17 | 2014-09-16 | Forsight Labs, Llc | Drug delivery treatment device |
EP3005996B1 (en) | 2006-01-17 | 2019-12-04 | Novartis Ag | Glaucoma treatment device |
ATE497797T1 (de) | 2006-03-14 | 2011-02-15 | Univ Southern California | Mems-vorrichtung zur wirkstofffreisetzung |
EP3449873A1 (en) * | 2006-03-31 | 2019-03-06 | Mati Therapeutics Inc. | Drug delivery structures and compositions for nasolacrimal system |
SG138567A1 (en) * | 2006-06-21 | 2008-01-28 | Johnson & Johnson Vision Care | Punctal plugs for the delivery of active agents |
US9474645B2 (en) * | 2006-06-21 | 2016-10-25 | Johnson & Johnson Vision Care, Inc. | Punctal plugs for the delivery of active agents |
BRPI0718696A2 (pt) | 2006-11-09 | 2013-12-31 | Alcon Res Ltd | Matriz de polímero insolúvel em água para liberação de fármaco. |
ZA200902588B (en) * | 2006-11-09 | 2010-06-30 | Alcon Res Ltd | Punctual plug comprising a water-insoluble polymeric matrix |
UY30883A1 (es) | 2007-01-31 | 2008-05-31 | Alcon Res | Tapones punctales y metodos de liberacion de agentes terapeuticos |
EP2173289A4 (en) | 2007-07-17 | 2010-11-24 | Transcend Medical Inc | EYE IMPLANT WITH HYDROGEL EXPANSION CAPABILITIES |
ES2732555T3 (es) * | 2007-09-07 | 2019-11-25 | Mati Therapeutics Inc | Implantes lagrimales y métodos relacionados |
MX2010002616A (es) * | 2007-09-07 | 2010-08-04 | Qlt Plug Delivery Inc | Nucleos de farmaco para la liberacion sostenida de agentes terapeuticos. |
JP2010537776A (ja) * | 2007-09-07 | 2010-12-09 | キューエルティー プラグ デリバリー,インク. | 涙管インプラント用の挿入および抜き取り工具 |
EP2205193A2 (en) | 2007-09-07 | 2010-07-14 | QLT Plug Delivery, Inc. | Lacrimal implant detection |
CA2705239C (en) * | 2007-11-08 | 2018-09-25 | Alimera Sciences, Inc. | Ocular implantation device |
CN101896221B (zh) | 2007-12-11 | 2013-06-05 | 麻省理工学院 | 用于治疗膀胱和其它体囊或体腔的可植入式药物递送设备和方法 |
US20100310622A1 (en) * | 2007-12-17 | 2010-12-09 | University Of Florida Research Foundation, Inc. | Dry eye treatment by puncta plugs |
MX364408B (es) | 2007-12-20 | 2019-04-25 | Univ Southern California | Aparatos y metodos para suministrar agentes terapeuticos. |
EP2222281B1 (en) | 2007-12-20 | 2018-12-05 | Evonik Corporation | Process for preparing microparticles having a low residual solvent volume |
CN102014816B (zh) * | 2008-02-18 | 2015-04-15 | 马缇医疗股份有限公司 | 泪管植入物及相关方法 |
JP5552482B2 (ja) * | 2008-04-30 | 2014-07-16 | キュー エル ティー インク. | 複合涙管挿入物および関連する方法 |
MX2010012213A (es) | 2008-05-08 | 2011-05-03 | Minipumps Llc | Bombas implantables y cánulas para las mismas. |
US9849238B2 (en) | 2008-05-08 | 2017-12-26 | Minipumps, Llc | Drug-delivery pump with intelligent control |
CN102202708B (zh) | 2008-05-08 | 2015-01-21 | 迷你泵有限责任公司 | 药物输送泵及其制造方法 |
BRPI0912182A2 (pt) * | 2008-05-09 | 2015-10-06 | Qlt Plug Delivery Inc | distribuição de liberação prolongada de agentes ativos pára tratar glaucoma e hipertensão ocular |
EP2303184A4 (en) * | 2008-06-24 | 2013-06-19 | Quadra Logic Tech Inc | GLAUCOMA ASSOCIATION TREATMENT |
US8617139B2 (en) | 2008-06-25 | 2013-12-31 | Transcend Medical, Inc. | Ocular implant with shape change capabilities |
EP2328527A1 (en) * | 2008-07-08 | 2011-06-08 | QLT Plug Delivery, Inc. | Lacrimal implant body including comforting agent |
BRPI0917135A2 (pt) | 2008-08-09 | 2015-11-10 | Massachusetts Inst Technology | dispositivo médico para extensão e retenção em uma vesícula seminal, duto ejaculatório, próstata ou vaso deferente de um paciente, uso de um elastômero reabsorvível, e, dispositivo de bomba osmótica. |
US20100204335A1 (en) * | 2008-12-01 | 2010-08-12 | Allergan, Inc. | Kit and composition for eyelash growth |
CA2747556A1 (en) * | 2008-12-19 | 2010-06-24 | Qlt Inc. | Substance delivering punctum implants and methods |
WO2010085696A2 (en) * | 2009-01-23 | 2010-07-29 | Qlt Plug Delivery Inc. | Sustained released delivery of one or more agents |
US8377122B2 (en) | 2009-01-28 | 2013-02-19 | Transcend Medical, Inc. | Ocular implant with stiffness qualities, methods of implantation and system |
US8623395B2 (en) | 2010-01-29 | 2014-01-07 | Forsight Vision4, Inc. | Implantable therapeutic device |
WO2010088548A1 (en) | 2009-01-29 | 2010-08-05 | Forsight Labs, Llc | Posterior segment drug delivery |
US20100204325A1 (en) * | 2009-02-11 | 2010-08-12 | Allergan, Inc. | Valproic acid drug delivery systems and intraocular therapeutic uses thereof |
WO2010093873A2 (en) * | 2009-02-12 | 2010-08-19 | Incept, Llc | Drug delivery through hydrogel plugs |
WO2010096822A2 (en) * | 2009-02-23 | 2010-08-26 | Qlt Plug Delivery, Inc. | Lacrimal implants and related methods |
WO2010107826A2 (en) | 2009-03-16 | 2010-09-23 | Endoshape, Inc. | Reliably retained shape memory ophthal-mological implants |
TWI495459B (zh) * | 2009-03-31 | 2015-08-11 | Johnson & Johnson Vision Care | 淚管塞(二) |
US9421127B2 (en) | 2009-03-31 | 2016-08-23 | Johnson & Johnson Vision Care, Inc. | Punctal plugs |
CN103494765A (zh) * | 2009-05-04 | 2014-01-08 | 普西维达公司 | 多孔硅药物洗脱颗粒 |
US10206813B2 (en) | 2009-05-18 | 2019-02-19 | Dose Medical Corporation | Implants with controlled drug delivery features and methods of using same |
EP2437684B1 (en) * | 2009-06-03 | 2022-06-15 | ForSight Vision5, Inc. | Anterior segment drug delivery |
DK2445571T3 (da) | 2009-06-26 | 2013-02-25 | Taris Biomedical Inc | Faste lægemiddeltabletter til implanterbare lægemiddelafgivelsesindretninger |
MX2012002063A (es) | 2009-08-18 | 2012-08-01 | Minipumps Llc | Bomba electrolitica para la administracion de farmacos con control adaptativo. |
US8808257B2 (en) * | 2009-08-31 | 2014-08-19 | Johnson & Johnson Vision Care, Inc. | Methods and apparatus for pulsatile release of medicaments from a punctal plug |
US9017312B2 (en) | 2009-09-10 | 2015-04-28 | Taris Biomedical Llc | Implantable device for controlled drug delivery |
JP2013512045A (ja) | 2009-11-27 | 2013-04-11 | キュー エル ティー インク. | スプリットと挿入可能な薬剤コアとを含む涙管インプラント |
US8529492B2 (en) | 2009-12-23 | 2013-09-10 | Trascend Medical, Inc. | Drug delivery devices and methods |
US9259352B2 (en) | 2010-03-29 | 2016-02-16 | Johnson & Johnson Vision Care, Inc. | Punctal plugs |
US9259351B2 (en) | 2010-03-29 | 2016-02-16 | Johnson & Johnson Vision Care, Inc. | Punctal plugs |
US20110251568A1 (en) * | 2010-04-08 | 2011-10-13 | Beeley Nathan R F | Punctal plugs for controlled release of therapeutic agents |
US9492315B2 (en) * | 2010-08-05 | 2016-11-15 | Forsight Vision4, Inc. | Implantable therapeutic device |
EP3711750B1 (en) | 2010-08-05 | 2023-09-06 | TARIS Biomedical LLC | Implantable drug delivery devices for genitourinary sites |
RS61601B1 (sr) | 2010-08-05 | 2021-04-29 | Forsight Vision4 Inc | Aparati za ubrizgavanje za dostavu leka |
US10617557B2 (en) | 2010-08-05 | 2020-04-14 | Forsight Vision4, Inc. | Combined drug delivery methods and apparatus |
US8821457B2 (en) * | 2010-09-08 | 2014-09-02 | Johnson & Johnson Vision Care, Inc. | Punctal plug containing drug formulation |
US8591484B2 (en) | 2010-09-15 | 2013-11-26 | AlphaMed, Inc. | Lacrimal punctum measurement and occlusion |
US9022967B2 (en) | 2010-10-08 | 2015-05-05 | Sinopsys Surgical, Inc. | Implant device, tool, and methods relating to treatment of paranasal sinuses |
CN104622789A (zh) | 2010-11-01 | 2015-05-20 | 普西维达公司 | 用于递送治疗剂的可生物侵蚀的硅基装置 |
US20140031769A1 (en) | 2010-11-19 | 2014-01-30 | Forsight Vision4, Inc. | Therapeutic agent formulations for implanted devices |
EP2643020A4 (en) * | 2010-11-26 | 2014-11-12 | Univ Witwatersrand Jhb | DEVICE FOR DELIVERY OF MEDICAMENT |
US20120157938A1 (en) * | 2010-12-16 | 2012-06-21 | Tokarski Jason M | Punctal plug with drug core retention features |
US9114111B2 (en) | 2011-01-10 | 2015-08-25 | Allergan, Inc. | Methods for sustained treatment of bladder pain and irritative voiding |
JP6043730B2 (ja) | 2011-02-04 | 2016-12-14 | タリス バイオメディカル エルエルシー | 低溶解性薬物の制御された放出のための植込み型装置 |
RU2456005C1 (ru) * | 2011-04-20 | 2012-07-20 | Общество с ограниченной ответственностью фирма "Биокор" | Способ приготовления биологически активного препарата |
EP3967297A1 (en) | 2011-04-29 | 2022-03-16 | Allergan, Inc. | Sustained release latanoprost implant |
US10245178B1 (en) | 2011-06-07 | 2019-04-02 | Glaukos Corporation | Anterior chamber drug-eluting ocular implant |
EP2726016B1 (en) | 2011-06-28 | 2023-07-19 | ForSight Vision4, Inc. | An apparatus for collecting a sample of fluid from a reservoir chamber of a therapeutic device for the eye |
EP2739252A4 (en) | 2011-08-05 | 2015-08-12 | Forsight Vision4 Inc | SMALL MOLECULE ADMINISTRATION USING AN IMPLANTABLE THERAPEUTIC DEVICE |
EP2750660B1 (en) | 2011-08-29 | 2016-10-12 | Mati Therapeutics Inc. | Sustained release delivery of active agents to treat glaucoma and ocular hypertension |
US9974685B2 (en) | 2011-08-29 | 2018-05-22 | Mati Therapeutics | Drug delivery system and methods of treating open angle glaucoma and ocular hypertension |
WO2013040426A2 (en) | 2011-09-14 | 2013-03-21 | Forsight Labs, Llc | Ocular insert apparatus and methods |
RS61758B1 (sr) | 2011-09-16 | 2021-05-31 | Forsight Vision4 Inc | Aparati za razmenu tečnosti |
US10226417B2 (en) | 2011-09-16 | 2019-03-12 | Peter Jarrett | Drug delivery systems and applications |
GB201120771D0 (en) * | 2011-12-02 | 2012-01-11 | Ljt Projects Ltd | tear duct resistance measuring system |
US8765210B2 (en) | 2011-12-08 | 2014-07-01 | Aquesys, Inc. | Systems and methods for making gelatin shunts |
TWI590843B (zh) | 2011-12-28 | 2017-07-11 | 信迪思有限公司 | 膜及其製造方法 |
US10010448B2 (en) | 2012-02-03 | 2018-07-03 | Forsight Vision4, Inc. | Insertion and removal methods and apparatus for therapeutic devices |
US10342700B2 (en) * | 2012-02-22 | 2019-07-09 | Ira H. Schachar | Device and method for treatment of retinal detachment and other maladies of the eye |
CA2807716C (en) * | 2012-02-29 | 2019-06-11 | Johnson & Johnson Vision Care, Inc. | Punctal plug with energized containment array |
EP2836170B1 (en) | 2012-04-11 | 2018-02-14 | Sinopsys Surgical, Inc. | Implantation tools, tool assemblies and kits |
US10085633B2 (en) | 2012-04-19 | 2018-10-02 | Novartis Ag | Direct visualization system for glaucoma treatment |
US9241832B2 (en) | 2012-04-24 | 2016-01-26 | Transcend Medical, Inc. | Delivery system for ocular implant |
CN105473130A (zh) | 2012-05-03 | 2016-04-06 | 麦提疗法有限公司 | 治疗开角型青光眼和高眼压症的药物递送系统和方法 |
KR101969594B1 (ko) * | 2012-05-11 | 2019-04-16 | 서강대학교산학협력단 | 안내 약물 전달 임플란트 |
EP3228286A1 (en) | 2012-09-17 | 2017-10-11 | Novartis AG | Expanding ocular impant devices |
DK2911623T3 (da) | 2012-10-26 | 2019-10-28 | Forsight Vision5 Inc | Oftalmisk system til langvarig frigivelse af lægemiddel til øjet |
WO2014078288A1 (en) | 2012-11-14 | 2014-05-22 | Transcend Medical, Inc. | Flow promoting ocular implant |
CN104968306B (zh) | 2013-01-25 | 2018-09-25 | 西诺普西斯外科股份有限公司 | 鼻窦进入植入装置及相关工具、方法和套件 |
US10159600B2 (en) | 2013-02-19 | 2018-12-25 | Aquesys, Inc. | Adjustable intraocular flow regulation |
US9125723B2 (en) | 2013-02-19 | 2015-09-08 | Aquesys, Inc. | Adjustable glaucoma implant |
EP2968113B8 (en) | 2013-03-14 | 2020-10-28 | Forsight Vision4, Inc. | Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant |
JP6517186B2 (ja) | 2013-03-15 | 2019-05-22 | タリス バイオメディカル エルエルシー | 薬物透過性構成部材を備えた薬物送達デバイス、及び方法 |
JP2016512839A (ja) | 2013-03-15 | 2016-05-09 | シヴィダ・ユーエス・インコーポレイテッドPsivida Us, Inc. | 治療物質の送達のための生体内分解性ケイ素系組成物 |
CA2907681C (en) | 2013-03-28 | 2022-11-22 | Forsight Vision4, Inc. | Ophthalmic implant for delivering therapeutic substances |
US9987163B2 (en) | 2013-04-16 | 2018-06-05 | Novartis Ag | Device for dispensing intraocular substances |
CN105555328B (zh) | 2013-06-21 | 2019-01-11 | 德普伊新特斯产品公司 | 膜及制造方法 |
AU2014309012B2 (en) | 2013-08-19 | 2019-03-14 | Taris Biomedical Llc | Multi-unit drug delivery devices and methods |
US9700459B2 (en) | 2013-10-16 | 2017-07-11 | Sinopsys Surgical, Inc. | Apparatuses, tools and kits relating to fluid manipulation treatments of paranasal sinuses |
KR102086103B1 (ko) | 2013-11-14 | 2020-03-06 | 아큐시스, 인코포레이티드 | 안구내 션트 삽입기 |
HU231309B1 (hu) | 2014-02-25 | 2022-11-28 | Darholding Kft. | Nanostrukturált Indomethacint, gyógyszerészetileg elfogadott sóit és kokristályait tartalmazó készítmény és eljárás előállításukra |
US20150342875A1 (en) | 2014-05-29 | 2015-12-03 | Dose Medical Corporation | Implants with controlled drug delivery features and methods of using same |
RU2695563C2 (ru) | 2014-07-15 | 2019-07-24 | Форсайт Вижн4, Инк. | Способ и устройство для доставки глазного имплантата |
EP3179968B1 (en) | 2014-07-24 | 2019-09-11 | Sinopsys Surgical, Inc. | Paranasal sinus access implant devices and related products and methods |
WO2016022750A1 (en) | 2014-08-08 | 2016-02-11 | Forsight Vision4, Inc. | Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof |
RU2562515C1 (ru) * | 2014-08-19 | 2015-09-10 | федеральное государственное бюджетное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации | Интубационный набор для биканаликулярного дренирования слезоотводящих путей |
CN106573133B (zh) | 2014-08-19 | 2020-03-03 | 加利福尼亚大学董事会 | 用于局部药物递送的植入物及其使用方法 |
US10507101B2 (en) | 2014-10-13 | 2019-12-17 | W. L. Gore & Associates, Inc. | Valved conduit |
JP7037360B2 (ja) | 2014-11-10 | 2022-03-16 | フォーサイト・ビジョン フォー・インコーポレーテッド | 拡張可能な薬物送達デバイス |
WO2016083891A1 (en) * | 2014-11-25 | 2016-06-02 | Eyal Sheetrit | Compositions and methods for delivering a bio-active agent or bio-active agents |
US11051982B2 (en) | 2014-12-17 | 2021-07-06 | Paul Gavaris | Canalicular plug, method and kit for treating dry eye |
RU2581823C1 (ru) * | 2015-03-17 | 2016-04-20 | федеральное государственное бюджетное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации | Дренаж для хирургического лечения глаукомы |
CN107529985B (zh) | 2015-03-31 | 2020-03-31 | 加州理工学院 | 用于长期可植入传感器和电子装置的生物相容性封装 |
US20160296532A1 (en) | 2015-04-13 | 2016-10-13 | Forsight Vision5, Inc. | Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent |
JP7425534B2 (ja) | 2015-04-23 | 2024-01-31 | タリス バイオメディカル エルエルシー | 薬物透過性構成要素を有する薬物送達デバイス及び方法 |
WO2016187355A1 (en) * | 2015-05-20 | 2016-11-24 | Glaukos Corporation | Therapeutic drug compositions and implants for delivery of same |
WO2016205107A1 (en) * | 2015-06-16 | 2016-12-22 | The Regents Of The University Of Colorado, A Body Corporate | Nasolacrimal implants and related methods for tear stimulation |
US20180193193A1 (en) * | 2015-07-06 | 2018-07-12 | The Regents Of The University Of Colorado, A Body Corporate | Lacrimal drainage system diagnostic implant |
JP2018525078A (ja) | 2015-07-22 | 2018-09-06 | インセプト・リミテッド・ライアビリティ・カンパニーIncept,Llc | 被覆された涙点プラグ |
WO2017040853A1 (en) | 2015-09-02 | 2017-03-09 | Glaukos Corporation | Drug delivery implants with bi-directional delivery capacity |
US11564833B2 (en) | 2015-09-25 | 2023-01-31 | Glaukos Corporation | Punctal implants with controlled drug delivery features and methods of using same |
US11458041B2 (en) | 2015-10-08 | 2022-10-04 | Ocular Therapeutix, Inc. | Punctal plug and bioadhesives |
WO2017087902A1 (en) | 2015-11-20 | 2017-05-26 | Forsight Vision4, Inc. | Porous structures for extended release drug delivery devices |
RU2613435C1 (ru) * | 2015-12-17 | 2017-03-16 | Федеральное государственное автономное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации | Дренаж для хирургического лечения глаукомы |
RU2620249C1 (ru) * | 2015-12-17 | 2017-05-23 | Федеральное государственное автономное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации | Многослойный биодеградируемый глазной имплантат с дозированным высвобождением лекарственного вещества и способ его изготовления |
US11007140B2 (en) * | 2015-12-21 | 2021-05-18 | Bayer Oy | Method for manufacturing a drug delivery device and a drug delivery device manufactured according to the method |
MX2018012021A (es) | 2016-04-05 | 2019-01-24 | Forsight Vision4 Inc | Dispositivos de administracion de farmacos oculares implantables. |
US11318043B2 (en) | 2016-04-20 | 2022-05-03 | Dose Medical Corporation | Bioresorbable ocular drug delivery device |
JP7054211B2 (ja) * | 2016-05-20 | 2022-04-13 | ザ リージェンツ オブ ザ ユニバーシティ オブ コロラド,ア ボディー コーポレイト | 涙腺ドラッグ送給デバイス |
GB2555373A (en) * | 2016-08-23 | 2018-05-02 | Reproductive Medicine And Gynaecology Associates Ltd | Implant |
ES2907847T3 (es) | 2016-09-30 | 2022-04-26 | Mati Therapeutics Inc | Formulación de liberación sostenida de fármaco oftálmico y sus usos |
US9925028B1 (en) * | 2016-11-15 | 2018-03-27 | Proximate Concepts Llc | Device for the delivery of a prosthetic implant and method of use thereof |
US10722335B1 (en) * | 2016-11-15 | 2020-07-28 | Proximate Concepts Llc | Device for the delivery of a prosthetic implant and method of use thereof |
US11523940B2 (en) | 2017-03-17 | 2022-12-13 | W. L. Gore & Associates, Inc. | Delivery aids for glaucoma shunts |
EP3621512B1 (en) * | 2017-05-12 | 2024-02-28 | California Institute of Technology | Implantable extracompartmental pressure sensor |
KR20200069261A (ko) * | 2017-05-30 | 2020-06-16 | 엑시모어 엘티디. | 항생제 마크로라이드를 전달하는 안구건조증을 치료하기 위한 조성물 및 방법 |
CA3067212A1 (en) | 2017-06-16 | 2018-12-20 | AesculaTech, Inc. | Thermoresponsive polymers and uses thereof |
US11332773B2 (en) | 2017-07-31 | 2022-05-17 | Keio University | Rapid tumorigenicity screening system |
AU2018338092A1 (en) | 2017-09-20 | 2020-03-19 | Sinopsys Surgical, Inc. | Paranasal sinus fluid access implantation tools, assemblies, kits and methods |
CN111432807A (zh) | 2017-10-06 | 2020-07-17 | 铸造疗法股份有限公司 | 用于控制释放治疗剂的可植入贮库 |
BR112020010053A2 (pt) | 2017-11-21 | 2020-11-03 | Forsight Vision4, Inc. | aparelho para troca de fluido para sistema de liberação de porta expansível e métodos de uso do mesmo |
CN111936093A (zh) * | 2018-03-22 | 2020-11-13 | 阿尔法米德有限公司 | 泪小管内可溶解的泪小点塞插入器 |
JP7352621B2 (ja) * | 2018-09-04 | 2023-09-28 | ユニバーシティ ホスピタルズ ヘルス システム,インコーポレイテッド | 緑内障治療用眼科装置及び関連低侵襲緑内障手術方法 |
US11678983B2 (en) | 2018-12-12 | 2023-06-20 | W. L. Gore & Associates, Inc. | Implantable component with socket |
US11850135B2 (en) | 2019-08-01 | 2023-12-26 | Paul H. Rosenberg Family Trust | Prosthetic implant delivery device utilizing surface active agents |
US11207267B2 (en) | 2019-10-02 | 2021-12-28 | Segal Innovations LLC | Bio-adhesive dissolving compounds and device |
US11701504B2 (en) | 2020-01-17 | 2023-07-18 | California Institute Of Technology | Implantable intracranial pressure sensor |
US20210251893A1 (en) | 2020-02-06 | 2021-08-19 | Ocular Therapeutix, Inc. | Compositions and Methods for Treating Ocular Diseases |
US11173291B2 (en) | 2020-03-20 | 2021-11-16 | The Regents Of The University Of California | Implantable drug delivery devices for localized drug delivery |
US11338119B2 (en) | 2020-03-20 | 2022-05-24 | The Regents Of The University Of California | Implantable drug delivery devices for localized drug delivery |
US11344526B2 (en) | 2020-03-20 | 2022-05-31 | The Regents Of The University Of California | Implantable drug delivery devices for localized drug delivery |
DK3884929T3 (da) | 2020-03-25 | 2023-09-25 | Ocular Therapeutix Inc | Øjenimplantat indeholdende en tyrosinkinase-inhibitor |
US20210338481A1 (en) * | 2020-04-20 | 2021-11-04 | Bruce B. Becker | Lacrimal gland implant for drug delivery and method |
EP3973952B1 (en) | 2020-09-24 | 2024-02-14 | Ocular Therapeutix, Inc. | Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporine |
Family Cites Families (244)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3880991A (en) * | 1969-03-24 | 1975-04-29 | Brook David E | Polymeric article for dispensing drugs |
US3865108A (en) | 1971-05-17 | 1975-02-11 | Ortho Pharma Corp | Expandable drug delivery device |
US3828777A (en) | 1971-11-08 | 1974-08-13 | Alza Corp | Microporous ocular device |
US3949750A (en) | 1974-10-07 | 1976-04-13 | Freeman Jerre M | Punctum plug and method for treating keratoconjunctivitis sicca (dry eye) and other ophthalmic aliments using same |
US4014335A (en) | 1975-04-21 | 1977-03-29 | Alza Corporation | Ocular drug delivery device |
US4281654A (en) | 1980-04-07 | 1981-08-04 | Alza Corporation | Drug delivery system for controlled ocular therapy |
US4304765A (en) * | 1980-10-14 | 1981-12-08 | Alza Corporation | Ocular insert housing steroid in two different therapeutic forms |
NZ200429A (en) * | 1981-04-30 | 1984-10-19 | Smith & Nephew Ass | Applicator for placing pharmaceutically active agent in contact with moist surface,e.g.,eye |
US5053030A (en) | 1984-11-07 | 1991-10-01 | Herrick Robert S | Intracanalicular implant for horizontal canalicular blockade treatment of the eye |
US4660546A (en) | 1984-11-07 | 1987-04-28 | Robert S. Herrick | Method for treating for deficiency of tears |
US5049142A (en) | 1984-11-07 | 1991-09-17 | Herrick Robert S | Intracanalicular implant for horizontal canalicular blockade treatment of the eye |
US5229128A (en) | 1986-06-11 | 1993-07-20 | Haddad Heskel M | Drug delivery ophthalmic insert and method of preparing same |
US5322691A (en) | 1986-10-02 | 1994-06-21 | Sohrab Darougar | Ocular insert with anchoring protrusions |
US4747404A (en) | 1986-11-10 | 1988-05-31 | Kresge Eye Institute Of Wayne State University | Foldable intraocular lens inserter |
US4886488A (en) | 1987-08-06 | 1989-12-12 | White Thomas C | Glaucoma drainage the lacrimal system and method |
GB8806367D0 (en) * | 1988-03-17 | 1988-04-13 | Erba Carlo Spa | Siloxane matrices with internal non-uniform drug distribution |
US4915684A (en) | 1988-06-21 | 1990-04-10 | Mackeen Donald L | Method and apparatus for modulating the flow of lacrimal fluid through a punctum and associated canaliculus |
US4915664A (en) | 1988-12-22 | 1990-04-10 | Erik Bakker | Toy glider with wing converging mechanism |
US5133159A (en) | 1989-01-13 | 1992-07-28 | Nestle S.A. | Method for polishing silicone products |
US4959048A (en) * | 1989-01-17 | 1990-09-25 | Helix Medical, Inc. | Lacrimal duct occluder |
US5098443A (en) | 1989-03-23 | 1992-03-24 | University Of Miami | Method of implanting intraocular and intraorbital implantable devices for the controlled release of pharmacological agents |
US5128058A (en) | 1989-05-31 | 1992-07-07 | Hoya Corporation | Contact lens cleaner containing a microcapsular polishing agent |
IE910450A1 (en) | 1990-02-15 | 1991-08-28 | Bausch & Lomb | Soft contact lens processing aid |
US5163959A (en) | 1990-03-29 | 1992-11-17 | Herrick Robert S | Method for treating an eye with a canalicular implant having a collapsible flared section |
US5171270A (en) | 1990-03-29 | 1992-12-15 | Herrick Robert S | Canalicular implant having a collapsible flared section and method |
US5041081A (en) | 1990-05-18 | 1991-08-20 | Odrich Ronald B | Ocular implant for controlling glaucoma |
US5116371A (en) | 1990-07-06 | 1992-05-26 | Christensen James M | Prosthesis with improved biocompatibility |
US5143724A (en) * | 1990-07-09 | 1992-09-01 | Biomatrix, Inc. | Biocompatible viscoelastic gel slurries, their preparation and use |
US5077033A (en) * | 1990-08-07 | 1991-12-31 | Mediventures Inc. | Ophthalmic drug delivery with thermo-irreversible gels of polxoxyalkylene polymer and ionic polysaccharide |
WO1993012765A1 (en) | 1991-12-27 | 1993-07-08 | Merck & Co., Inc. | A controlled release drug dispersion delivery device |
US5283063A (en) | 1992-01-31 | 1994-02-01 | Eagle Vision | Punctum plug method and apparatus |
US5334137A (en) | 1992-02-21 | 1994-08-02 | Eagle Vision, Inc. | Lacrimal fluid control device |
US5254089A (en) * | 1992-04-02 | 1993-10-19 | Boston Scientific Corp. | Medication dispensing balloon catheter |
US5178635A (en) | 1992-05-04 | 1993-01-12 | Allergan, Inc. | Method for determining amount of medication in an implantable device |
US5514379A (en) * | 1992-08-07 | 1996-05-07 | The General Hospital Corporation | Hydrogel compositions and methods of use |
US5469867A (en) | 1992-09-02 | 1995-11-28 | Landec Corporation | Cast-in place thermoplastic channel occluder |
US5318513A (en) | 1992-09-24 | 1994-06-07 | Leib Martin L | Canalicular balloon fixation stent |
FR2700265B1 (fr) * | 1993-01-08 | 1995-03-31 | France Chirurgie Instr | Bouchon méatique pour pathologie lacrymale. |
US5707643A (en) | 1993-02-26 | 1998-01-13 | Santen Pharmaceutical Co., Ltd. | Biodegradable scleral plug |
US6117907A (en) * | 1993-04-14 | 2000-09-12 | Sher; Neal A. | Topical treatment of ocular pain after corneal surgery |
US5824048A (en) | 1993-04-26 | 1998-10-20 | Medtronic, Inc. | Method for delivering a therapeutic substance to a body lumen |
US5417651A (en) | 1993-07-01 | 1995-05-23 | Guena; Nicolas | Punctum plug and monocanalicular probe for lacrimal pathology |
US5770589A (en) | 1993-07-27 | 1998-06-23 | The University Of Sydney | Treatment of macular degeneration |
US5423777A (en) | 1993-10-27 | 1995-06-13 | Tajiri; Akira | Punctum plug |
US5443505A (en) * | 1993-11-15 | 1995-08-22 | Oculex Pharmaceuticals, Inc. | Biocompatible ocular implants |
US6350781B1 (en) * | 1994-01-14 | 2002-02-26 | Lee Shahinia, Jr. | Method and analgesic preparations for sustained and extended corneal analgesia with subanesthetic concentrations of lidocaine |
US5466233A (en) | 1994-04-25 | 1995-11-14 | Escalon Ophthalmics, Inc. | Tack for intraocular drug delivery and method for inserting and removing same |
JP3486758B2 (ja) | 1994-06-24 | 2004-01-13 | 株式会社高研 | 注入可能な涙小管閉鎖剤 |
JPH0878130A (ja) | 1994-09-08 | 1996-03-22 | Wako:Kk | 接地極の埋設方法 |
US6416760B2 (en) | 1995-01-26 | 2002-07-09 | Societe L'oreal | Therapeutic/cosmetic compositions comprising CGRP antagonists for treating sensitive human skin |
CN1124164C (zh) * | 1995-05-14 | 2003-10-15 | 奥普通诺尔有限公司 | 眼内植入物 |
JPH11507269A (ja) * | 1995-06-07 | 1999-06-29 | ケラビジョン,インコーポレイテッド | 基質内角膜半径方向挿入物および挿入方法 |
US6149684A (en) | 1995-06-07 | 2000-11-21 | Herrick; Robert S. | Punctum plug having a thin elongated lip and a distal starting tip and method of using |
US5723005A (en) | 1995-06-07 | 1998-03-03 | Herrick Family Limited Partnership | Punctum plug having a collapsible flared section and method |
US5766243A (en) | 1995-08-21 | 1998-06-16 | Oasis Medical, Inc. | Abrasive polished canalicular implant |
US5773019A (en) | 1995-09-27 | 1998-06-30 | The University Of Kentucky Research Foundation | Implantable controlled release device to deliver drugs directly to an internal portion of the body |
US5741292A (en) | 1995-10-26 | 1998-04-21 | Eagle Vision | Punctum dilating and plug inserting instrument with push-button plug release |
US6441047B2 (en) | 1995-11-17 | 2002-08-27 | Alcon Manufacturing Ltd.. | Combination therapy for treating glaucoma |
WO1997020578A1 (en) * | 1995-12-04 | 1997-06-12 | University Of Miami | Non-preserved topical corticosteroid for treatment of dry eye, filamentary keratitis, and delayed tear clearance |
US5824073A (en) | 1996-03-18 | 1998-10-20 | Peyman; Gholam A. | Macular indentor for use in the treatment of subretinal neovascular membranes |
FR2747033B1 (fr) * | 1996-04-03 | 1998-05-22 | Parrat Michel Jesus Hubert | Obturateur meatique dynamique pour canalicules lacrymaux |
JP3675035B2 (ja) | 1996-06-10 | 2005-07-27 | トヨタ自動車株式会社 | 内燃機関の燃料噴射量制御装置 |
JPH1033584A (ja) | 1996-07-26 | 1998-02-10 | M L C:Kk | 涙道挿管器具 |
US5928662A (en) * | 1996-07-31 | 1999-07-27 | Phillips; Andrew F. | Ocular drug delivery device |
JP3345428B2 (ja) | 1996-08-20 | 2002-11-18 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 合成甲状腺ホルマン組成物を使用した眼の処置 |
US5993407A (en) | 1996-10-25 | 1999-11-30 | Moazed; Kambiz Thomas | Transnasal lacrimal insert |
US6010391A (en) | 1996-11-01 | 2000-01-04 | Alcon Laboratories, Inc. | Cryogenic polishing method for soft acrylic articles |
US6254562B1 (en) | 1997-02-04 | 2001-07-03 | Alain Fouere | Meatus plug for lachrymal canal capable of being screwed |
US6041785A (en) | 1997-03-27 | 2000-03-28 | Eaglevision, Inc. | Punctum plug |
US6016806A (en) | 1997-03-27 | 2000-01-25 | Eaglevision, Inc | Punctum plug |
US6027470A (en) | 1998-06-10 | 2000-02-22 | Eagle Vision, Inc. | Punctum plug and method for inserting the same into the punctual opening |
US6082362A (en) | 1997-03-27 | 2000-07-04 | Eagle Vision, Inc. | Punctum plug |
DE69809222T2 (de) * | 1997-05-07 | 2003-08-14 | Galen Chemicals Ltd | Vorrichtungen zur intravaginalen verabreichung von testosteron und testosteron-vorläuferverbindungen |
US5961370A (en) | 1997-05-08 | 1999-10-05 | Chiron Vision Corporation | Intraocular lens tumbling process using coated beads |
MY125870A (en) | 1997-07-25 | 2006-08-30 | Alza Corp | Osmotic delivery system flow modulator apparatus and method |
US6306426B1 (en) | 1997-08-11 | 2001-10-23 | Allergan Sales, Inc. | Implant device with a retinoid for improved biocompatibility |
US5830171A (en) | 1997-08-12 | 1998-11-03 | Odyssey Medical, Inc. | Punctal occluder |
US5902598A (en) * | 1997-08-28 | 1999-05-11 | Control Delivery Systems, Inc. | Sustained release drug delivery devices |
US6060439A (en) | 1997-09-29 | 2000-05-09 | Kyzen Corporation | Cleaning compositions and methods for cleaning resin and polymeric materials used in manufacture |
US6335335B2 (en) | 1997-11-05 | 2002-01-01 | Senju Pharmaceutical Co., Ltd. | Prolonged-action eye drop |
US5947974A (en) | 1997-12-09 | 1999-09-07 | Allergan | Folding device and method for an intraocular lens |
US6646001B2 (en) | 1997-12-19 | 2003-11-11 | Alcon Manufacturing, Ltd. | Use of non-steroidal anti-inflammatory agents in combination with prostaglandin FP receptor agonists to treat glaucoma and ocular hypertension |
NL1008090C2 (nl) | 1998-01-22 | 1999-07-26 | Lubberman Bernardus H M | Plug voor het afsluiten van een traanbuis. |
WO1999044553A1 (en) | 1998-03-02 | 1999-09-10 | Herrick Family Limited Partnership | A punctum plug having a collapsible flared section and method |
US6290684B1 (en) | 1998-03-02 | 2001-09-18 | Herrick Family Limited Partnership | Punctum plug having a collapsible expanded section and distal tip extending substantially perpendicular thereto and method of inserting same |
US6512747B1 (en) | 1998-03-05 | 2003-01-28 | Nippon Telegraph And Telephone Corporation | ATM transmission system |
US6196993B1 (en) | 1998-04-20 | 2001-03-06 | Eyelab Group, Llc | Ophthalmic insert and method for sustained release of medication to the eye |
US6224630B1 (en) * | 1998-05-29 | 2001-05-01 | Advanced Bio Surfaces, Inc. | Implantable tissue repair device |
US6015433A (en) * | 1998-05-29 | 2000-01-18 | Micro Therapeutics, Inc. | Rolled stent with waveform perforation pattern |
US6306114B1 (en) | 1998-06-16 | 2001-10-23 | Eagle Vision, Inc. | Valved canalicular plug for lacrimal duct occlusion |
US6117441A (en) * | 1998-07-02 | 2000-09-12 | The Population Council, Inc. | Silicone core long term androgen delivery implant |
CN1114401C (zh) | 1998-07-14 | 2003-07-16 | 阿尔康实验室公司 | 11-(3-二甲氨基亚丙基)-6,11-二氢二苯并[b,e]噁庚英-2-乙酸用于制药的新用途 |
US6225348B1 (en) * | 1998-08-20 | 2001-05-01 | Alfred W. Paulsen | Method of treating macular degeneration with a prostaglandin derivative |
JP2000070296A (ja) | 1998-08-27 | 2000-03-07 | M L C:Kk | 涙道内挿管器具 |
US6095901A (en) | 1998-12-09 | 2000-08-01 | Alcon Laboratories, Inc. | Polishing method for soft acrylic articles |
US20040121014A1 (en) | 1999-03-22 | 2004-06-24 | Control Delivery Systems, Inc. | Method for treating and/or preventing retinal diseases with sustained release corticosteroids |
US6234175B1 (en) | 1999-03-23 | 2001-05-22 | Medennium, Inc. | Smart ocular plug design and method of insertion for punctal and intracanalicular implants |
US6383192B1 (en) | 1999-04-28 | 2002-05-07 | Mlc Limited Company | Apparatus for intubation of lacrimal duct |
US6428502B1 (en) | 1999-06-25 | 2002-08-06 | Alcon Manufacturing, Ltd. | Punctal cannula |
US6706275B1 (en) | 1999-09-08 | 2004-03-16 | Matthew W. Camp | Scleral plug system |
DE60016271T2 (de) * | 1999-10-21 | 2005-12-01 | Alcon Inc. | Medikamentenzuführvorrichtung |
US6331313B1 (en) | 1999-10-22 | 2001-12-18 | Oculex Pharmaceticals, Inc. | Controlled-release biocompatible ocular drug delivery implant devices and methods |
US6264971B1 (en) | 1999-11-04 | 2001-07-24 | Btg International Limited | Ocular insert |
US6566345B2 (en) | 2000-04-28 | 2003-05-20 | Fziomed, Inc. | Polyacid/polyalkylene oxide foams and gels and methods for their delivery |
US20050119737A1 (en) * | 2000-01-12 | 2005-06-02 | Bene Eric A. | Ocular implant and methods for making and using same |
US6344047B1 (en) | 2000-02-02 | 2002-02-05 | Eagle Vision | Instrument for inserting a punctum plug and method for manufacturing the instrument |
US7708711B2 (en) | 2000-04-14 | 2010-05-04 | Glaukos Corporation | Ocular implant with therapeutic agents and methods thereof |
US6638239B1 (en) | 2000-04-14 | 2003-10-28 | Glaukos Corporation | Apparatus and method for treating glaucoma |
US7867186B2 (en) | 2002-04-08 | 2011-01-11 | Glaukos Corporation | Devices and methods for treatment of ocular disorders |
US6375972B1 (en) | 2000-04-26 | 2002-04-23 | Control Delivery Systems, Inc. | Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
US20040208910A1 (en) * | 2000-04-26 | 2004-10-21 | Control Delivery Systems, Inc. | Sustained release device and method for ocular delivery of adrenergic agents |
US20040175410A1 (en) | 2000-04-26 | 2004-09-09 | Control Delivery Systems, Inc. | Sustained release device and method for ocular delivery of carbonic anhydrase inhibitors |
US6371122B1 (en) | 2000-06-20 | 2002-04-16 | Robert M. Mandelkorn | Gauge/dilator apparatus |
US6629533B1 (en) | 2000-06-30 | 2003-10-07 | Eagle Vision, Inc. | Punctum plug with at least one anchoring arm |
AU2001234337A1 (en) * | 2000-08-04 | 2002-02-18 | Medennium, Inc. | Ocular plug for punctal and intracanalicular implants |
US6534693B2 (en) | 2000-11-06 | 2003-03-18 | Afmedica, Inc. | Surgically implanted devices having reduced scar tissue formation |
WO2002056863A2 (en) | 2000-12-29 | 2002-07-25 | Bausch & Lomb Incorporated | Sustained release drug delivery devices |
US7041868B2 (en) * | 2000-12-29 | 2006-05-09 | Kimberly-Clark Worldwide, Inc. | Bioabsorbable wound dressing |
CA2432225C (en) | 2001-01-03 | 2008-01-15 | Michael J. Brubaker | Sustained release drug delivery devices with prefabricated permeable plugs |
WO2002058667A2 (en) | 2001-01-26 | 2002-08-01 | Bausch & Lomb Incorporated | Improved process for the production of sustained release drug delivery devices |
US20020193441A1 (en) | 2001-02-21 | 2002-12-19 | Robertson Stella M. | Prostanoid therapies for the treatment of glaucoma |
US6713081B2 (en) | 2001-03-15 | 2004-03-30 | The United States Of America As Represented By The Department Of Health And Human Services | Ocular therapeutic agent delivery devices and methods for making and using such devices |
US6981958B1 (en) | 2001-05-02 | 2006-01-03 | Glaukos Corporation | Implant with pressure sensor for glaucoma treatment |
US7431710B2 (en) | 2002-04-08 | 2008-10-07 | Glaukos Corporation | Ocular implants with anchors and methods thereof |
ES2304438T3 (es) | 2001-04-07 | 2008-10-16 | Glaukos Corporation | Stent de glaucoma para el tratamiento del glaucoma. |
US6605108B2 (en) | 2001-04-13 | 2003-08-12 | Eagle Vision, Inc. | Monocanalicular stent |
US6982090B2 (en) | 2001-05-10 | 2006-01-03 | Gillespie Donald E | More easily visualized punctum plug configurations |
US7404825B2 (en) | 2001-06-11 | 2008-07-29 | Herrick Ii Robert S | Implant capable of forming a differential image in an eye |
US6743439B1 (en) * | 2001-06-27 | 2004-06-01 | Alcon, Inc. | Ophthalmic compositions containing copolymers of sulfonated styrene and maleic anhydride |
JP4249611B2 (ja) * | 2001-07-23 | 2009-04-02 | アルコン,インコーポレイティド | 眼薬剤送致装置 |
KR20040024873A (ko) * | 2001-08-03 | 2004-03-22 | 글루코마 리서치 테크널러지스 인코포레이션 | 녹내장과 노안 치료를 위한 공막내 이식장치와 그 방법 |
FR2829019B3 (fr) | 2001-08-31 | 2003-10-31 | Alain Fouere | Bouchons lacrymaux et methodes de mise en place de ces dispositifs |
WO2003022242A1 (en) | 2001-09-11 | 2003-03-20 | Smart Drug Systems Inc | Preparation of sustained release pharmaceutical composition |
US6996063B2 (en) | 2001-11-16 | 2006-02-07 | Asustek Computer Inc. | Applicable PDU range test and calculation for window-based polling |
FR2833175B1 (fr) | 2001-12-06 | 2004-05-14 | Sobem | Dispositif de controle de debit, a usage medical |
US7001615B1 (en) | 2001-12-07 | 2006-02-21 | Alcon, Inc. | Sustained release ophthalmic, otic and nasal suspension |
US6729939B2 (en) | 2001-12-17 | 2004-05-04 | Bausch & Lomb Incorporated | Polishing method for intraocular lens |
FR2834446B1 (fr) | 2002-01-08 | 2004-02-13 | Ioltechnologie Production | Clou meatique a expansion |
CA2473355C (en) * | 2002-01-18 | 2012-01-03 | Michael E. Snyder | Sustained release ophthalmological device and method of making and using the same |
JP4262601B2 (ja) | 2002-01-18 | 2009-05-13 | タカラバイオ株式会社 | 硫酸化フカン |
TW200305424A (en) * | 2002-01-29 | 2003-11-01 | Santen Pharmaceutical Co Ltd | Glaucoma-treating agent comprising bunazosin and prostaglandin |
US7204995B2 (en) | 2002-01-31 | 2007-04-17 | El-Sherif Dalia M | Treatment and control of dry eye by use of biodegradable polymer capsules |
US20040116524A1 (en) * | 2002-02-04 | 2004-06-17 | Cohen Ben Z. | Method of administering opthalmic fluids |
CN1638743B (zh) * | 2002-03-11 | 2012-11-07 | 爱尔康公司 | 可植入药物的释放系统 |
US9301875B2 (en) | 2002-04-08 | 2016-04-05 | Glaukos Corporation | Ocular disorder treatment implants with multiple opening |
US20040147870A1 (en) | 2002-04-08 | 2004-07-29 | Burns Thomas W. | Glaucoma treatment kit |
JP2005532313A (ja) * | 2002-05-07 | 2005-10-27 | コントロール・デリバリー・システムズ・インコーポレイテッド | 薬物送達装置の形成方法 |
US8871241B2 (en) | 2002-05-07 | 2014-10-28 | Psivida Us, Inc. | Injectable sustained release delivery devices |
US20040043067A1 (en) | 2002-06-19 | 2004-03-04 | Salamone Joseph C. | Fluorosiloxane matrix controlled diffusion drug delivery systems |
US6866563B2 (en) | 2002-06-27 | 2005-03-15 | Bausch & Lomb Incorporated | Apparatus and method for target polishing intraocular lenses |
FR2841770B1 (fr) | 2002-07-05 | 2004-10-01 | Ioltechnologie Production | Clou meatique d'obturation d'un meat lacrymal |
FR2844182B1 (fr) | 2002-09-11 | 2004-12-03 | Humanoptics Ag | Bouchon d'obturation d'un canalicule lacrymal |
US7169163B2 (en) | 2002-09-30 | 2007-01-30 | Bruce Becker | Transnasal method and catheter for lacrimal system |
US7785578B2 (en) | 2002-10-11 | 2010-08-31 | Aciont, Inc. | Non-invasive ocular drug delivery |
EP1411745B1 (en) | 2002-10-16 | 2007-08-08 | Alcatel Lucent | Packet switching for packet data transmission systems in a multi-channel radio arrangement |
US7354574B2 (en) * | 2002-11-07 | 2008-04-08 | Advanced Ocular Systems Limited | Treatment of ocular disease |
US7580394B2 (en) | 2002-11-27 | 2009-08-25 | Nokia Corporation | System and method for collision-free transmission scheduling in a network |
NZ540885A (en) | 2002-12-20 | 2009-02-28 | Chakshu Res Inc | Ophthalmic formulation for the prevention and treatment of ocular conditions |
US20040144392A1 (en) * | 2003-01-23 | 2004-07-29 | Mueller Richard L. | Breast nipple duct protective device |
ES2332720T3 (es) * | 2003-01-24 | 2010-02-11 | Psivida Us Inc. | Dispositivo y procedimiento de liberacion sostenida para la administracion ocular de agentes adrenergicos. |
DE602004024642D1 (de) * | 2003-01-24 | 2010-01-28 | Psivida Inc | Vorrichtung zur verlängerten freisetzung und methode zur okularen verabreichung von carboanhydrase inhibitoren |
US8149707B2 (en) | 2003-02-12 | 2012-04-03 | Rockstar Bidco, LP | Minimization of radio resource usage in multi-hop networks with multiple routings |
EP1603485A4 (en) * | 2003-02-26 | 2011-03-30 | Medivas Llc | BIOACTIVE STENTS AND METHOD OF USE THEREOF |
EP2330213A1 (en) * | 2003-03-05 | 2011-06-08 | Halozyme, Inc. | Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
US20050283109A1 (en) | 2003-03-07 | 2005-12-22 | Peyman Gholam A | Method and apparatus for lacrimal canal obstruction |
US7065376B2 (en) | 2003-03-20 | 2006-06-20 | Microsoft Corporation | Multi-radio unification protocol |
US20040193095A1 (en) * | 2003-03-29 | 2004-09-30 | Shadduck John H. | Implants for treating ocular hypertension, methods of use and methods of fabrication |
US20050255144A1 (en) * | 2003-04-09 | 2005-11-17 | Directcontact Llc | Methods and articles for the delivery of medicaments to the eye for the treatment of posterior segment diseases |
EP1633320A2 (en) | 2003-05-02 | 2006-03-15 | SurModics, Inc. | Implantable controlled release bioactive agent delivery device |
US7017580B2 (en) | 2003-05-22 | 2006-03-28 | Clarity Corporation | Punctum plug system including a punctum plug and passive insertion tool therefor |
US7204253B2 (en) | 2003-05-22 | 2007-04-17 | Clarity Corporation | Punctum plug |
US20040236343A1 (en) | 2003-05-23 | 2004-11-25 | Taylor Jon B. | Insertion tool for ocular implant and method for using same |
CA2467410A1 (en) * | 2003-05-27 | 2004-11-27 | Synphora Ab | Method for treatment of glaucoma and ocular hypertension with prostaglandin analgoues without melanogenic side-effect |
JP4104137B2 (ja) | 2003-05-30 | 2008-06-18 | 有限会社エム・エル・シー | 涙点プラグ |
US7662864B2 (en) * | 2003-06-04 | 2010-02-16 | Rutgers, The State University Of New Jersey | Solution polymerization processes to prepare a polymer that degrades to release a physiologically active agent |
JP4339635B2 (ja) | 2003-06-12 | 2009-10-07 | 有限会社エム・エル・シー | 涙点プラグ |
US6994684B2 (en) | 2003-06-16 | 2006-02-07 | Alphamed Inc. | Punctum plugs having fluid collecting recesses and methods of punctal occlusion |
US20040265356A1 (en) | 2003-06-30 | 2004-12-30 | Bausch & Lomb Incorporated | Drug delivery device |
CN1822815B (zh) | 2003-07-10 | 2012-04-11 | 沃纳奇尔科特(爱尔兰)有限公司 | 阴道内药物传递装置 |
JP4280128B2 (ja) | 2003-08-19 | 2009-06-17 | 有限会社エム・エル・シー | 涙点プラグ |
AU2004274026A1 (en) * | 2003-09-18 | 2005-03-31 | Macusight, Inc. | Transscleral delivery |
JP2007507498A (ja) * | 2003-10-03 | 2007-03-29 | アラーガン、インコーポレイテッド | 充血の少ない緑内障処置のためのプロスタグランジン関連化合物およびトレフォイルファクターファミリーペプチドを含む組成物および方法 |
JP2005110765A (ja) | 2003-10-03 | 2005-04-28 | M L C:Kk | 涙点プラグセット |
JP2005110930A (ja) | 2003-10-07 | 2005-04-28 | M L C:Kk | 涙点プラグセット |
US20050129731A1 (en) | 2003-11-03 | 2005-06-16 | Roland Horres | Biocompatible, biostable coating of medical surfaces |
US20050095269A1 (en) | 2003-11-04 | 2005-05-05 | Ainpour Parviz R. | Gel plug for blockage of the canaliculus |
AU2004292957C1 (en) | 2003-11-13 | 2011-04-28 | Eyepoint Pharmaceuticals Us, Inc. | Injectable sustained release implant having a bioerodible matrix core and a bioerodible skin |
US7291125B2 (en) | 2003-11-14 | 2007-11-06 | Transcend Medical, Inc. | Ocular pressure regulation |
WO2005060302A1 (en) | 2003-12-17 | 2005-06-30 | Telefonaktiebolaget Lm Ericsson (Publ) | A method, system, terminal and computer program product for selecting radio access system in a multiaccess system |
US7752519B2 (en) | 2003-12-29 | 2010-07-06 | Electronics And Telecommunications Research Institute | Method for creating feedback message for ARQ in mobile communication system |
US20050197614A1 (en) | 2004-03-04 | 2005-09-08 | Wilson Pritchard | Occlusive biomedical devices, punctum plugs, and methods of use thereof |
US20050220882A1 (en) | 2004-03-04 | 2005-10-06 | Wilson Pritchard | Materials for medical implants and occlusive devices |
US20050232972A1 (en) | 2004-04-15 | 2005-10-20 | Steven Odrich | Drug delivery via punctal plug |
JP2004202276A (ja) | 2004-04-16 | 2004-07-22 | M L C:Kk | 涙道再建用挿管器具 |
US8425929B2 (en) * | 2004-04-30 | 2013-04-23 | Allergan, Inc. | Sustained release intraocular implants and methods for preventing retinal dysfunction |
JP2005312835A (ja) | 2004-04-30 | 2005-11-10 | M L C:Kk | 糸で補強した涙道ステント |
US20050244461A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Controlled release drug delivery systems and methods for treatment of an eye |
US7799336B2 (en) * | 2004-04-30 | 2010-09-21 | Allergan, Inc. | Hypotensive lipid-containing biodegradable intraocular implants and related methods |
US20050244469A1 (en) | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Extended therapeutic effect ocular implant treatments |
JP4644438B2 (ja) | 2004-05-11 | 2011-03-02 | 有限会社エム・エル・シー | ツバつき涙道ステント |
JP4510511B2 (ja) | 2004-05-18 | 2010-07-28 | 有限会社エム・エル・シー | ツバを円盤で補強した涙道ステント及び涙道プラグ |
CA2572592C (en) | 2004-07-02 | 2015-09-08 | Eliot Lazar | Treatment medium delivery device and methods for delivery of such treatment mediums to the eye using such a delivery device |
US7117870B2 (en) * | 2004-07-26 | 2006-10-10 | Clarity Corporation | Lacrimal insert having reservoir with controlled release of medication and method of manufacturing the same |
US20060020253A1 (en) | 2004-07-26 | 2006-01-26 | Prescott Anthony D | Implantable device having reservoir with controlled release of medication and method of manufacturing the same |
WO2006014793A1 (en) | 2004-07-26 | 2006-02-09 | Clarity Corporation | Implantable device having reservoir with controlled release of medication and method of manufacturing the same |
US20080038317A1 (en) | 2004-09-10 | 2008-02-14 | Chin-Ming Chang | Therapeutic Lacrimal Canalicular Inserts And Related Methods |
US20060074370A1 (en) | 2004-09-24 | 2006-04-06 | Medennium, Inc. | Ocular occluder and method of insertion |
RU2007115853A (ru) * | 2004-10-04 | 2008-11-10 | КьюЭлТи ЮЭсЭй, ИНК. (US) | Композиция, применимая в качестве имплантата с контролируемым высвобождением |
JP2008521489A (ja) | 2004-11-24 | 2008-06-26 | テラカイン コーポレイション | 眼球内薬物送達のための移植物 |
CN1790976A (zh) | 2004-12-17 | 2006-06-21 | 松下电器产业株式会社 | 用于多天线传输中的重传方法 |
US7986633B2 (en) | 2004-12-27 | 2011-07-26 | Lg Electronics Inc. | Method of controlling data transmission for multimedia and broadcasting services in a broadband wireless access system |
CN100394900C (zh) * | 2005-02-02 | 2008-06-18 | 周星 | 螺旋弹簧型人工泪道 |
DE602005001441T2 (de) | 2005-03-04 | 2007-10-31 | Matsushita Electric Industrial Co., Ltd., Kadoma | Verfahren und Vorrichtung zur Synchronisation der physikalischen Protokollschichten in heterogenen Mobilkommunikationsnetzwerken |
US20060233858A1 (en) | 2005-03-08 | 2006-10-19 | Allergan, Inc. | Systems and methods providing targeted intraocular drug delivery |
WO2006122414A1 (en) * | 2005-05-17 | 2006-11-23 | Matregen Corp. | Depot for sustained and controlled delivery of methotrexate |
US20060292099A1 (en) * | 2005-05-25 | 2006-12-28 | Michael Milburn | Treatment of eye disorders with sirtuin modulators |
WO2007009061A2 (en) * | 2005-07-13 | 2007-01-18 | Anthrogenesis Corporation | Ocular plug formed from placenta derived collagen biofabric |
US7862532B2 (en) | 2005-10-07 | 2011-01-04 | Delta Life Sciences, Inc. | Punctum plugs having insertion guides and strengthening beams |
US20070088444A1 (en) * | 2005-10-13 | 2007-04-19 | Robert A Hodorek | Method for repairing a bone defect using a formable implant which hardens in vivo |
US20070132125A1 (en) | 2005-12-08 | 2007-06-14 | Bausch & Lomb Incorporated | Use of a super-cooled fluid in lens processing |
JP4078371B2 (ja) | 2006-01-27 | 2008-04-23 | 章弘 小栗 | 涙点プラグ |
EP3449873A1 (en) | 2006-03-31 | 2019-03-06 | Mati Therapeutics Inc. | Drug delivery structures and compositions for nasolacrimal system |
US9173773B2 (en) | 2006-06-21 | 2015-11-03 | Johnson & Johnson Vision Care, Inc. | Punctal plugs for the delivery of active agents |
US20080045911A1 (en) | 2006-06-21 | 2008-02-21 | Borgia Maureen J | Punctal plugs for the delivery of active agents |
US9474645B2 (en) | 2006-06-21 | 2016-10-25 | Johnson & Johnson Vision Care, Inc. | Punctal plugs for the delivery of active agents |
JP2009544355A (ja) * | 2006-07-20 | 2009-12-17 | ニューロシステック コーポレイション | 眼科薬物送達のためのデバイス、システム、および方法 |
FR2908042B1 (fr) | 2006-11-08 | 2009-06-05 | Bruno Fayet | Ensemble d'intubation monocanaliculonasal et/ou monocanaliculaire,notamment pour l'imperforation lacrymonasale. |
AU2007339929A1 (en) * | 2006-12-26 | 2008-07-10 | Qlt Inc. | Drug delivery implants for inhibition of optical defects |
UY30883A1 (es) | 2007-01-31 | 2008-05-31 | Alcon Res | Tapones punctales y metodos de liberacion de agentes terapeuticos |
US20080299176A1 (en) | 2007-05-30 | 2008-12-04 | Yu-Chin Lai | Drug delivery device comprising crosslinked polyurethane-siloxane-containing copolymers |
EP2205193A2 (en) | 2007-09-07 | 2010-07-14 | QLT Plug Delivery, Inc. | Lacrimal implant detection |
JP2010537776A (ja) | 2007-09-07 | 2010-12-09 | キューエルティー プラグ デリバリー,インク. | 涙管インプラント用の挿入および抜き取り工具 |
WO2009035565A1 (en) | 2007-09-07 | 2009-03-19 | Qlt Plug Delivery, Inc | Prostaglandin analogues for implant devices and methods |
ES2732555T3 (es) | 2007-09-07 | 2019-11-25 | Mati Therapeutics Inc | Implantes lagrimales y métodos relacionados |
MX2010002616A (es) | 2007-09-07 | 2010-08-04 | Qlt Plug Delivery Inc | Nucleos de farmaco para la liberacion sostenida de agentes terapeuticos. |
CN102014816B (zh) | 2008-02-18 | 2015-04-15 | 马缇医疗股份有限公司 | 泪管植入物及相关方法 |
JP5552482B2 (ja) | 2008-04-30 | 2014-07-16 | キュー エル ティー インク. | 複合涙管挿入物および関連する方法 |
BRPI0912182A2 (pt) | 2008-05-09 | 2015-10-06 | Qlt Plug Delivery Inc | distribuição de liberação prolongada de agentes ativos pára tratar glaucoma e hipertensão ocular |
MX2010013010A (es) | 2008-05-30 | 2011-05-03 | Qlt Plug Delivery Inc | Articulos implantables tratados en la superficie y metodos relacionados. |
EP2303184A4 (en) | 2008-06-24 | 2013-06-19 | Quadra Logic Tech Inc | GLAUCOMA ASSOCIATION TREATMENT |
EP2328527A1 (en) | 2008-07-08 | 2011-06-08 | QLT Plug Delivery, Inc. | Lacrimal implant body including comforting agent |
CA2747556A1 (en) | 2008-12-19 | 2010-06-24 | Qlt Inc. | Substance delivering punctum implants and methods |
WO2010085696A2 (en) | 2009-01-23 | 2010-07-29 | Qlt Plug Delivery Inc. | Sustained released delivery of one or more agents |
WO2010096822A2 (en) | 2009-02-23 | 2010-08-26 | Qlt Plug Delivery, Inc. | Lacrimal implants and related methods |
-
2007
- 2007-04-02 EP EP18199593.7A patent/EP3449873A1/en not_active Withdrawn
- 2007-04-02 NZ NZ595349A patent/NZ595349A/xx unknown
- 2007-04-02 NZ NZ571758A patent/NZ571758A/en unknown
- 2007-04-02 CN CN201310338528.5A patent/CN103393496B/zh active Active
- 2007-04-02 BR BRPI0709663-1A patent/BRPI0709663A2/pt not_active Application Discontinuation
- 2007-04-02 CA CA2648421A patent/CA2648421C/en active Active
- 2007-04-02 DK DK07759961.1T patent/DK2010096T3/en active
- 2007-04-02 DK DK07759964.5T patent/DK2004172T3/en active
- 2007-04-02 WO PCT/US2007/065789 patent/WO2007115259A2/en active Application Filing
- 2007-04-02 KR KR1020117003795A patent/KR20110038144A/ko not_active Application Discontinuation
- 2007-04-02 EP EP07759961.1A patent/EP2010096B1/en active Active
- 2007-04-02 ES ES07759964T patent/ES2717607T3/es active Active
- 2007-04-02 RU RU2008143224/14A patent/RU2414199C2/ru active
- 2007-04-02 JP JP2009503334A patent/JP2009532132A/ja active Pending
- 2007-04-02 CN CN201310329155.5A patent/CN103393483B/zh active Active
- 2007-04-02 US US11/695,545 patent/US7998497B2/en active Active
- 2007-04-02 KR KR1020087026781A patent/KR20090006153A/ko active Search and Examination
- 2007-04-02 WO PCT/US2007/065792 patent/WO2007115261A2/en active Application Filing
- 2007-04-02 NZ NZ572193A patent/NZ572193A/en unknown
- 2007-04-02 KR KR1020127008750A patent/KR101270113B1/ko active IP Right Grant
- 2007-04-02 BR BRPI0709672A patent/BRPI0709672B8/pt active IP Right Grant
- 2007-04-02 AU AU2007234447A patent/AU2007234447B2/en active Active
- 2007-04-02 JP JP2009503335A patent/JP5208916B2/ja active Active
- 2007-04-02 CA CA2648066A patent/CA2648066C/en active Active
- 2007-04-02 EP EP07759964.5A patent/EP2004172B1/en active Active
- 2007-04-02 MX MX2008012601A patent/MX2008012601A/es not_active Application Discontinuation
- 2007-04-02 RU RU2008143223/14A patent/RU2413480C2/ru active
- 2007-04-02 SG SG201102311-6A patent/SG170816A1/en unknown
- 2007-04-02 ES ES07759961.1T patent/ES2640458T3/es active Active
- 2007-04-02 US US11/695,537 patent/US8795711B2/en active Active
- 2007-04-02 KR KR1020087026758A patent/KR101062796B1/ko active IP Right Grant
- 2007-04-02 NZ NZ595623A patent/NZ595623A/xx unknown
- 2007-04-02 MX MX2008012603A patent/MX2008012603A/es active IP Right Grant
- 2007-04-02 AU AU2007234445A patent/AU2007234445B2/en active Active
- 2007-04-02 SG SG201102260-5A patent/SG170806A1/en unknown
-
2008
- 2008-10-02 ZA ZA200808401A patent/ZA200808401B/xx unknown
- 2008-10-02 IL IL194514A patent/IL194514A0/en unknown
- 2008-10-02 IL IL194515A patent/IL194515A/en not_active IP Right Cessation
- 2008-10-13 NO NO20084275A patent/NO20084275L/no not_active Application Discontinuation
- 2008-10-21 ZA ZA200809003A patent/ZA200809003B/xx unknown
- 2008-10-23 NO NO20084471A patent/NO20084471L/no not_active Application Discontinuation
- 2008-12-10 US US12/332,219 patent/US20090092654A1/en not_active Abandoned
-
2010
- 2010-11-30 RU RU2010149066/14A patent/RU2010149066A/ru not_active Application Discontinuation
- 2010-12-03 RU RU2010149861/14A patent/RU2010149861A/ru not_active Application Discontinuation
-
2011
- 2011-04-03 IL IL212113A patent/IL212113A/en active IP Right Grant
- 2011-04-03 IL IL212114A patent/IL212114A/en active IP Right Grant
- 2011-07-18 US US13/184,690 patent/US8747884B2/en active Active
-
2012
- 2012-08-02 JP JP2012171816A patent/JP2012228571A/ja active Pending
- 2012-10-04 US US13/645,261 patent/US8691265B2/en active Active
-
2013
- 2013-04-18 IL IL225842A patent/IL225842B/en active IP Right Grant
- 2013-11-01 JP JP2013228144A patent/JP2014087650A/ja active Pending
-
2014
- 2014-02-14 US US14/180,592 patent/US9610194B2/en active Active
- 2014-04-29 US US14/265,071 patent/US9168222B2/en active Active
- 2014-04-30 HK HK14104156.6A patent/HK1190908A1/zh unknown
- 2014-04-30 HK HK14104157.5A patent/HK1190909A1/zh unknown
- 2014-07-16 US US14/333,349 patent/US20140328894A1/en not_active Abandoned
- 2014-07-24 JP JP2014150364A patent/JP6279421B2/ja active Active
-
2015
- 2015-01-16 US US14/598,262 patent/US20150224200A1/en not_active Abandoned
- 2015-09-18 US US14/858,555 patent/US9549852B2/en active Active
-
2016
- 2016-11-01 JP JP2016213964A patent/JP2017060789A/ja not_active Ceased
-
2017
- 2017-01-13 US US15/405,991 patent/US9849082B2/en active Active
- 2017-05-11 JP JP2017094500A patent/JP2017148605A/ja active Pending
- 2017-12-22 US US15/852,619 patent/US10383817B2/en active Active
-
2018
- 2018-05-11 JP JP2018091793A patent/JP2018187396A/ja active Pending
- 2018-10-23 US US16/168,335 patent/US11406592B2/en active Active
- 2018-10-23 US US16/168,554 patent/US10300014B2/en active Active
-
2019
- 2019-08-02 JP JP2019142914A patent/JP2019213885A/ja active Pending
- 2019-08-19 US US16/544,884 patent/US10874606B2/en active Active
-
2020
- 2020-12-24 US US17/133,980 patent/US20210212941A1/en active Pending
-
2021
- 2021-05-17 JP JP2021082984A patent/JP7273891B2/ja active Active
-
2022
- 2022-08-06 US US17/882,552 patent/US20230165791A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2010149861A (ru) | Имплантаты назолакримальной дренажной системы для медикаментозной терапии | |
ES2355385T3 (es) | Tapones de cierre para una abertura en una pared de un vaso o bien órgano hueco. | |
CA3044673C (en) | Device and method for artificial insemination | |
ES2376585T3 (es) | Pinza de protección de agujas con reborde. | |
RU2010136822A (ru) | Лакримальные имплантаты и связанные с ними способы | |
DE60144524D1 (de) | Pharmazeutische zubereitung und methode diese zu verabreichen | |
WO2005107705A3 (en) | Extended therapeutic effect ocular implant treatments | |
US6306120B1 (en) | Applicator and method for delivery of mitomycin to eye tissues during glaucoma filtering surgery | |
WO2008024982A2 (en) | Ophthalmic insert | |
DE69633074D1 (de) | Intraokulares implantat, einführgerät sowie implantierungsverfahren | |
WO2007131050A3 (en) | Method for drug delivery to ocular tissue using microneedle | |
DE60112554D1 (de) | Intragastrale vorrichtung zur behandlung der morbiden fettsucht | |
EP2029195A2 (en) | Implantable pump for drug delivery to treat erectile dysfunction | |
US5618274A (en) | Method and device for deep pressurized topical, fornix applied "nerve block" anesthesia | |
WO2007077551A3 (en) | Device and method for treating the anal sphincter | |
CN203154060U (zh) | 一种泪道探查及治疗装置 | |
WO2005063204A3 (en) | Drug delivery device with suture ring | |
CN109688987B (zh) | 勃起功能障碍患者用安全套 | |
KR20120128911A (ko) | 요도삽입장치 보조 기구 | |
KR200471253Y1 (ko) | 요도삽입장치 보조 기구 | |
AU779087B2 (en) | Insertion device | |
WO2005065644A3 (en) | Drug delivery device with mesh based suture tab | |
AU712617B2 (en) | Delivery system | |
JP2006204900A (ja) | 摘便器 | |
RO119810B1 (ro) | Aparat pentru erecţia artificială a penisului |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA93 | Acknowledgement of application withdrawn (no request for examination) |
Effective date: 20131204 |